Literature DB >> 1606944

Small intestinal volvulus in adults of Gonder Region, northwestern Ethiopia.

A Tegegne1.   

Abstract

A review of intestinal obstruction in Gonder revealed that small intestinal volvulus in adults is the most common cause of small intestinal obstruction, and it ranked only second to sigmoid volvulus as the most common cause of all intestinal obstruction. Out of 25 patients 23 had primary and the remaining 2 secondary small intestinal volvulus. The secondary small intestinal volvulus occurred in patients both of whom had previous gangrenous sigmoid volvulus that was resected. The disease was predominantly seen in young, adult, male farmers. Though early diagnosis is one of the most important factors in the final outcome of the treatment, the diagnostic accuracy preoperatively is said to be low. In this study diagnosis by exclusion of the common causes of small intestinal obstruction in the region improved the preoperative diagnostic accuracy.

Entities:  

Mesh:

Year:  1992        PMID: 1606944

Source DB:  PubMed          Journal:  Ethiop Med J        ISSN: 0014-1755


  4 in total

1.  Surgical Management Outcome of Intestinal Obstruction and Its Associated Factors at University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia, 2018.

Authors:  Tesfamichael G Mariam; Addisu Taye Abate; Mehammed Adem Getnet
Journal:  Surg Res Pract       Date:  2019-07-28

2.  Pattern of adult intestinal obstruction at Tenwek hospital, in south-western Kenya.

Authors:  Philip Blasto Ooko; Betty Sirera; Seno Saruni; Hillary Mariko Topazian; Russell White
Journal:  Pan Afr Med J       Date:  2015-01-13

3.  Ileo-ileal knotting as an uncommon cause of acute intestinal obstruction.

Authors:  Engida Abebe; Biruhtesfa Asmare; Abebe Addise
Journal:  J Surg Case Rep       Date:  2015-08-06

4.  Small bowel volvulus (SBV) in Northcentral Ethiopia.

Authors:  Atalel Fentahun Awedew; Woldemariam Beka Belay; Bedemariam Tadesse Amsalu; Dawit Zerihun Yalewu
Journal:  BMC Surg       Date:  2020-10-02       Impact factor: 2.102

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.